Inogen Inc

Company Profile

Inogen Inc had its IPO on 2014-02-14 under the ticker symbol INGN.

The company operates in the Healthcare sector and Medical Devices industry. Inogen Inc has a staff strength of 1,026 employees.

Stock update

Shares of Inogen Inc opened at $5.8 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $5.8 - $6, and closed at $5.9.

This is a +0.85% increase from the previous day's closing price.

A total volume of 176,066 shares were traded at the close of the day’s session.

In the last one week, shares of Inogen Inc have slipped by -4.53%.

Inogen Inc's Key Ratios

Inogen Inc has a market cap of $135.69 million, indicating a price to book ratio of 1.368 and a price to sales ratio of 1.2841.

In the last 12-months Inogen Inc’s revenue was $349.28 million with a gross profit of $153.53 million and an EBITDA of $-40947000. The EBITDA ratio measures Inogen Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Inogen Inc’s operating margin was -17.54% while its return on assets stood at -9.07% with a return of equity of -30.51%.

In Q2, Inogen Inc’s quarterly earnings growth was a positive 87.3% while revenue growth was a negative 19.1%.

Inogen Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

3.48

Its diluted EPS in the last 12-months stands at $-4.11 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 3.48. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Inogen Inc’s profitability.

Inogen Inc stock is trading at a EV to sales ratio of 0.8056 and a EV to EBITDA ratio of -29.0874. Its price to sales ratio in the trailing 12-months stood at 1.2841.

Inogen Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$374.35 million

Total Liabilities

$59.37 million

Operating Cash Flow

$0

Capital Expenditure

$8.61 million

Dividend Payout Ratio

0%

Inogen Inc ended 2024 with $374.35 million in total assets and $0 in total liabilities. Its intangible assets were valued at $374.35 million while shareholder equity stood at $274.78 million.

Inogen Inc ended 2024 with $0 in deferred long-term liabilities, $59.37 million in other current liabilities, 23000.00 in common stock, $-44675000.00 in retained earnings and $32.89 million in goodwill. Its cash balance stood at $167.69 million and cash and short-term investments were $170.15 million. The company’s total short-term debt was $3,622,000 while long-term debt stood at $0.

Inogen Inc’s total current assets stands at $269.22 million while long-term investments were $0 and short-term investments were $2.46 million. Its net receivables were $52.96 million compared to accounts payable of $27.61 million and inventory worth $30.74 million.

In 2024, Inogen Inc's operating cash flow was $0 while its capital expenditure stood at $8.61 million.

Comparatively, Inogen Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$5.9

52-Week High

$27.92

52-Week Low

$5.525

Analyst Target Price

$15

Inogen Inc stock is currently trading at $5.9 per share. It touched a 52-week high of $27.92 and a 52-week low of $27.92. Analysts tracking the stock have a 12-month average target price of $15.

Its 50-day moving average was $7.56 and 200-day moving average was $14.21 The short ratio stood at 1.38 indicating a short percent outstanding of 0%.

Around 96.3% of the company’s stock are held by insiders while 10036% are held by institutions.